Cassava Sciences(SAVA) - 2024 Q2 - Earnings Call Transcript
Cassava Sciences, Inc. (NASDAQ:SAVA) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Richard Barry - Executive Chairman of the Board James Kupiec - Chief Medical Officer Eric Schoen - Chief Financial Officer Christopher Cook - Senior Vice President and General Counsel Conference Call Participants Soumit Roy - Jones Trading Institutional Services LLC Vernon Bernardino - H.C. Wainwright Elemer Piros - Rodman and Renshaw Operator Welcome to Cassava Sciences Reports for the Secon ...